Rotavirus epidemiology: The Asian Rotavirus Surveillance Network

Vaccine

Volumn 26, Issue 26, 2008, Pages 3192-3196

  Nelson, E A S ^a,d   Bresee, J S ^b,d   Parashar, U D ^b,d   Widdowson, M A ^b,d   Glass, R I ^c,d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d Asian Rotavirus Surveillance Network Members   (China)

Author keywords

Disease burden; Economic evaluation; Immunization; Policy; Rotavirus; Surveillance

Indexed keywords

ROTAVIRUS VACCINE;

CHILDHOOD MORTALITY; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIARRHEA; DISEASE SURVEILLANCE; DRUG COST; GASTROENTERITIS; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SURVEY; HOSPITALIZATION; HUMAN; HUMAN ROTAVIRUS; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INTUSSUSCEPTION; PRIORITY JOURNAL; REVIEW; SEASONAL VARIATION; STRAIN DIFFERENCE; VIRUS INFECTION; VIRUS STRAIN; WORLD HEALTH ORGANIZATION;

ASIA; DIARRHEA; HUMANS; POPULATION SURVEILLANCE; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 50949098035     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.03.073     Document Type: Review

References (39)

1. Centers for Disease Control and Prevention. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Wkly 1999;48(March, RR-2):1-20.
2. Nelson E.A., Ko W.K., Kwan E., et al. Guidelines for the management of acute diarrhoea in young children. Hong Kong J Paediatr 8 (2003) 203-236
3. Glass R.I., Parashar U.D., Bresee J.S., et al. Rotavirus vaccines: current prospects and future challenges. Lancet 368 July 22, 9532 (2006) 323-332
4. McCarthy M. Project seeks to "fast track" rotavirus vaccine. Lancet 361 February 15, 9357 (2003) 582
5. Bresee J., Fang Z.Y., Wang B., et al. First report from the Asian Rotavirus Surveillance Network. Emerg Infect Dis 10 June 6 (2004) 988-995
6. WHO. Generic protocol for (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community-based survey on utilization of health care services for gastroenteritis in children. Field test version (WHO/V&B/02.15). WHO publication 2002; Report no.: WHO/V&B/02.15.
7. Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine-United States, 1998-1999. MMWR Wkly 1999;48(July, 1627):577-81.
8. Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Wkly 1999;48(November 5, 43):1007.
9. Murphy T.V., Gargiullo P.M., Massoudi M.S., et al. Intussusception among infants given an oral rotavirus vaccine. New Engl J Med 344 February 22, 8 (2001) 564-572
10. Kramarz P., France E.K., Destefano F., et al. Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J 20 April 1 (2001) 410-416
11. Glass R.I., Bresee J.S., Parashar U.D., Jiang B., and Gentsch J. The future of rotavirus vaccines: a major setback leads to new opportunities. Lancet 363 May 8, 9420 (2004) 1547-1550
12. Murphy B.R., Morens D.M., Simonsen L., Chanock R.M., La Montagne J.R., and Kapikian A.Z. Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. J Infect Dis 187 April 15, 8 (2003) 1301-1308
13. Simonsen L., Viboud C., Elixhauser A., Taylor R.J., and Kapikian A.Z. More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis 192 September 1, Suppl. 1 (2005) S36-S43
14. Hong Kong Intussusception Study Group (Nelson, EAS, Chiu SS, Ip KS, Lau D, Lau YL, Ng CH, Ng DK, Poon KH, Yiu WL, Kwok WK, Tam P, Yeung CK, Tam JS, Bock H, Boudville I, Tang HH). Intussusception trends in Hong Kong children. Hong Kong Med J 13 4 (2007) 279-283
15. Bresee J.S., Hummelman E., Nelson E.A., and Glass R.I. Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines. J Infect Dis 192 September 1, Suppl. 1 (2005) S1-S5
16. Fang Z.Y., Wang B., Kilgore P.E., et al. Sentinel hospital surveillance for rotavirus diarrhea in the People's Republic of China, August 2001-July 2003. J Infect Dis 192 September 1, Suppl. 1 (2005) S94-S99
17. Wang X.Y., Xu Z.Y., von Seidlein L., et al. Incidence of diarrhea caused by rotavirus infections in rural Zhengding, China: prospective, population-based surveillance. J Infect Dis 192 September 1, Suppl. 1 (2005) S100-S105
18. Nelson E.A., Tam J.S., Bresee J.S., et al. Estimates of rotavirus disease burden in Hong Kong: hospital-based surveillance. J Infect Dis 192 September 1, Suppl. 1 (2005) S71-S79
19. Kim J.S., Kang J.O., Cho S.C., et al. Epidemiological profile of rotavirus infection in the Republic of Korea: results from prospective surveillance in the Jeongeub District, July 1, 2002 through June 30, 2004. J Infect Dis 192 September 1, Suppl. 1 (2005) S49-S56
20. Hsu V.P., Abdul Rahman H.B., Wong S.L., et al. Estimates of the burden of rotavirus disease in Malaysia. J Infect Dis 192 September 1, Suppl. 1 (2005) S80-S86
21. Moe K., Hummelman E.G., Oo W.M., Lwin T., and Htwe T.T. Hospital-based surveillance for rotavirus diarrhea in children in Yangon, Myanmar. J Infect Dis 192 September 1, Suppl. 1 (2005) S111-S113
22. Chen K.T., Chen P.Y., Tang R.B., et al. Sentinel hospital surveillance for rotavirus diarrhea in Taiwan, 2001-2003. J Infect Dis 192 September 1, Suppl. 1 (2005) S44-S48
23. Jiraphongsa C., Bresee J.S., Pongsuwanna Y., et al. Epidemiology and burden of rotavirus diarrhea in Thailand: results of sentinel surveillance. J Infect Dis 192 September 1, Suppl. 1 (2005) S87-S93
24. Van Man N., Luan lT, Trach D.D., et al. Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003. J Infect Dis 192 September 1, Suppl. 1 (2005) S127-S132
25. Nakagomi T., Nakagomi O., Takahashi Y., Enoki M., Suzuki T., and Kilgore P.E. Incidence and burden of rotavirus gastroenteritis in Japan, as estimated from a prospective sentinel hospital study. J Infect Dis 192 September 1, Suppl. 1 (2005) S106-S110
26. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., and Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9 May 5 (2003) 565-572
27. Gentsch J.R., Laird A.R., Bielfelt B., et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 192 September 1, Suppl. 1 (2005) S146-S159
28. Nelson E.A., Tam J.S., Yu L.M., et al. Hospital-based study of the economic burden associated with rotavirus diarrhea in Hong Kong. J Infect Dis 192 September 1, Suppl. 1 (2005) S64-S70
29. Tucker A.W., Haddix A.C., Bresee J.S., Holman R.C., Parashar U.D., and Glass R.I. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA 279 May 6, 17 (1998) 1371-1376
30. Podewils L.J., Antil L., Hummelman E., Bresee J., Parashar U.D., and Rheingans R. Projected cost-effectiveness of rotavirus vaccination for children in Asia. J Infect Dis 192 September 1, Suppl. 1 (2005) S133-S145
31. Vesikari T., Matson D.O., Dennehy P., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New Engl J Med 354 January 5, 1 (2006) 23-33
32. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. New Engl J Med 354 January 5, 1 (2006) 11-22
33. Kapikian A.Z., Simonsen L., Vesikari T., et al. A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception. J Infect Dis 192 September 1, Suppl. 1 (2005) S22-S29
34. Glass R.I., Bhan M.K., Ray P., et al. Development of candidate rotavirus vaccines derived from neonatal strains in India. J Infect Dis 192 September 1, Suppl. 1 (2005) S30-S35
35. Glass R.I., Bresee J.S., Turcios R., Fischer T.K., Parashar U.D., and Steele A.D. Rotavirus vaccines: targeting the developing world. J Infect Dis 192 September 1, Suppl. 1 (2005) S160-S166
36. Wuethrich B. Rotavirus and rotavirus vaccines: proceedings of the sixth international rotavirus symposium (2005), The Albert B. Sabin Vaccine Institute, Washington
37. World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec 82 August 10, 32 (2007) 285-295
38. Nelson E.A., Bresee J.S., Choi K.C., Mast T.C., DiStefano D., and Tam J.S. Rotavirus genotypes and clinical severity in Hong Kong over three rotavirus seasons (2006), The Commonwealth Association of Paediatric Gastroenterology and Nutrition, Dhaka, Bangladesh
39. Kang J.O., Kilgore P., Kim J.S., et al. Molecular epidemiological profile of rotavirus in South Korea, July 2002 through June 2003: emergence of G4P[6] and G9P[8] strains. J Infect Dis 192 September 1, Suppl. 1 (2005) S57-S63